El Vínculo El Vínculo.
Awarded European Union SuppliesFramework agreement

Furnizare Medicamente Oncologice

Buyer: Institutul de Pneumoftiziologie "Marius Nasta"

Published
26 March 2024
Procedure
Open procedure
Notice number
00181176-2024
Reference
4193d970-99e8-4118-901a-9240092678cb
Official source
Official source

CPV codes

Description

Furnizare medicamente Termenul limita pana la care orice operator economic interesat are dreptul de a solicita clarificari sau informatii suplimentare in legatura cu documentatia de atribuire este de 18 zile inainte de data limita de depunere a ofertelor. B. In conformitate cu prevederile art. 160 alin. (2) din Legea nr. 98/2016 autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 11-a zi inainte de termenul limita stabilit pentru depunerea ofertelor, în masura în care sunt transmise în termenul precizat.

Lots (37)

LotDescriptionCPV codeAmount
1 PEMETREXEDUM
RO321
33652100 Agentes antineoplásicos
2 VINORELBINUM 1 ml
RO321
33652100 Agentes antineoplásicos
3 VINORELBINUM 5 ml
RO321
33652100 Agentes antineoplásicos
4 ETOPOSIDUM 5 ml
RO321
33652100 Agentes antineoplásicos
5 ETOPOSIDUM 10 ml
RO321
33652100 Agentes antineoplásicos
6 ETOPOSIDUM 100mg/5ml
RO321
33652100 Agentes antineoplásicos
7 DOCETAXELUM 160mg/8ml
RO321
33652100 Agentes antineoplásicos
8 DOCETAXELUM 20mg/1ml
RO321
33652100 Agentes antineoplásicos
9 DOCETAXELUM 80mg/4ml
RO321
33652100 Agentes antineoplásicos
10 DOCETAXELUM 20mg/ml
RO321
33652100 Agentes antineoplásicos
11 DOCETAXELUM 20mg/ml fl 7 ml
RO321
33652100 Agentes antineoplásicos
12 DOCETAXELUM 120mg/6ml
RO321
33652100 Agentes antineoplásicos
13 CAELYX - DOXORUBICINUM 2mg/ml
RO321
33652100 Agentes antineoplásicos
14 DOXORUBICINUM 2mg/ml
RO321
33652100 Agentes antineoplásicos
15 DOXORUBICINUM 2mg/ml - 25 ml
RO321
33652100 Agentes antineoplásicos
16 DOXORUBICINUM 2mg/ml - 8 ml
RO321
33652100 Agentes antineoplásicos
17 DOXORUBICINUM 2mg/ml - 50 ml
RO321
33652100 Agentes antineoplásicos
18 CISPLATINUM 10mg/ 20 ml
RO321
33652100 Agentes antineoplásicos
19 CISPLATINUM 1mg/ml
RO321
33652100 Agentes antineoplásicos
20 CISPLATINUM 1mg/ml - 25 ml
RO321
33652100 Agentes antineoplásicos
21 CISPLATINUM 1mg/ml - 50 ml
RO321
33652100 Agentes antineoplásicos
22 CISPLATINUM 1mg/ml - 100 ml
RO321
33652100 Agentes antineoplásicos
23 TOPOTECAMUM 1mg/ml
RO321
33652100 Agentes antineoplásicos
24 TOPOTECAMUM 1mg/ml - 5ml
RO321
33652100 Agentes antineoplásicos
25 TOPOTECAMUM 4mg
RO321
33652100 Agentes antineoplásicos
26 FILGRASTIMUM 30MU/0,5 ml
RO321
33652100 Agentes antineoplásicos
27 FILGRASTIMUM 48MU/0,5 ml
RO321
33652100 Agentes antineoplásicos
28 PEGFILGRASTIMUM 10mg/ml
RO321
33652100 Agentes antineoplásicos
29 PEGFILGRASTIMUM 6mg
RO321
33652100 Agentes antineoplásicos
30 CALCII FOLINAS 10mg/ml
RO321
33652100 Agentes antineoplásicos

Award criteria

Awards

Awarded toAmountDate
FILDAS TRADING S.R.L. 30,920,560 RON
MEDIPLUS EXIM 30,876,000 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON
ALLIANCE HEALTHCARE ROMÂNIA SRL 30,843,360 RON

Official publications

Other tenders from Institutul de Pneumoftiziologie "Marius Nasta"

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is Institutul de Pneumoftiziologie "Marius Nasta" (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.